0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Cancer Biomarkers
 1-19 of 19 Articles
Research Letter | 
Michael E. Zavaski, MD; Christian P. Meyer, MD; Jesse D. Sammon, DO; et al.
JAMA Intern Med. 2016;176(4):546-547. doi:10.1001/jamainternmed.2015.7901.

Viewpoint | 
Anne Marie McCarthy, ScM, PhD; Katrina Armstrong, MD, MSCE
JAMA Intern Med. 2014;174(7):1023-1024. doi:10.1001/jamainternmed.2014.1322.

Original Investigation |  FREE
Marlies S. Reimers, MD; Esther Bastiaannet, PhD; Ruth E. Langley, MD; et al.
JAMA Intern Med. 2014;174(5):732-739. doi:10.1001/jamainternmed.2014.511.
Includes: Supplemental Content

Research Letters |  FREE
Sunita Sah, MD, MBA, PhD; Pierre Elias, BA; Dan Ariely, PhD
JAMA Intern Med. 2013;173(10):932-933. doi:10.1001/jamainternmed.2013.401.

Editor's Correspondence | 
Giuseppe Lippi, MD; Camilla Mattiuzzi, MD; Gianfranco Cervellin, MD
JAMA Intern Med. 2013;173(5):392. doi:10.1001/jamainternmed.2013.2173.

Invited Commentary | 
Victor Grann, MD, MPH; Maxine Ashby-Thompson, MPH
JAMA Intern Med. 2013;173(2):103-104. doi:10.1001/jamainternmed.2013.2729.

Editor's Correspondence | 
Paul Ross Casner, MD, PhD
Arch Intern Med. 2012;172(14):1110-1114. doi:10.1001/archinternmed.2012.2038.

Editor's Correspondence | 
Deborah Grady, MD, MPH; Rita F. Redberg, MD, MSc
Arch Intern Med. 2012;172(14):1110-1114. doi:10.1001/archinternmed.2012.2637.

Editorial | 
Robin Leach, PhD; Ian M. Thompson, MD
Arch Intern Med. 2012;172(11):835-836. doi:10.1001/archinternmed.2012.1226.

Invited Commentary | 
Brenda E. Sirovich, MD, MS
Arch Intern Med. 2012;172(5):411-413. doi:10.1001/archinternmed.2012.62.

Editor's Correspondence | 
Alan I. Glaser, MD
Arch Intern Med. 2011;171(6):594-595. doi:10.1001/archinternmed.2011.80.

Original Investigation |  FREE
Yu-Hsuan Shao, PhD; Peter C. Albertsen, MD; Calpurnyia B. Roberts, PhD; et al.
Arch Intern Med. 2010;170(14):1256-1261. doi:10.1001/archinternmed.2010.221.

Original Investigation |  FREE
Wildon R. Farwell, MD, MPH; Jeffrey A. Linder, MD, MPH; Ashish K. Jha, MD, MPH
Arch Intern Med. 2007;167(22):2497-2502. doi:10.1001/archinte.167.22.2497.

Editorial | 
Michael J. Barry, MD
Arch Intern Med. 2006;166(1):7-8. doi:10.1001/archinte.166.1.7.

Editor's Correspondence | 
Donald B. Louria, MD
Arch Intern Med. 2005;165(6):702. doi:10.1001/archinte.165.6.702-a.

Controversies in Internal Medicine | 
Siam Oottamasathien, MD; E. David Crawford, MD
Arch Intern Med. 2003;163(6):661-663. doi:10.1001/archinte.163.6.661.

Editor's Correspondence | 
Nasir Shahab, MD
Arch Intern Med. 2002;162(8):949-950. doi:.

Editor's Correspondence | 
Alper Sevinc, MD; Ramazan Sari, MD; Suleyman Buyukberber, MD
Arch Intern Med. 2001;161(20):2507-2508. doi:.

Editor's Correspondence | 
Y. L. Kwong, MD; W. Y. Au, MRCP
Arch Intern Med. 2001;161(20):2508. doi:.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Review  | 
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton, MD, PhD; Sylvia Adams, MD; Mary L. Disis, MD
JAMA Cardiology
Brief Report  | 
Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure
Gregg C. Fonarow, MD; Adrian F. Hernandez, MD, MHS; Scott D. Solomon, MD; et al.
JAMA Oncology
Research Letter  | 
Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma
David Liu, MD, MPH, MS; Elizabeth R. Plimack, MD, MS; Jean Hoffman-Censits, MD; et al.